Liver Elastography (ARFI)

The following liver-related problems are detected and assessed using liver elastography:

• Liver Fibrosis: Liver elastography aids in determining the extent of liver fibrosis, which is scarring of liver tissue caused by chronic inflammation. It can determine the extent of fibrosis and whether it is progressing, which is useful for treatment planning.
• Cirrhosis: Cirrhosis is a severe form of liver fibrosis in which extensive scarring interferes with normal liver function. Elastography aids in the diagnosis and severity assessment of cirrhosis. Cirrhosis detection at an early stage is critical for managing and preventing complications.
• NAFLD and NASH: Elastography is used to assess liver stiffness in people with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), both of which are caused by fat accumulation in the liver.
• Hepatitis B and C: Elastography can help assess liver stiffness in people who have chronic hepatitis B or C infections. It elucidates the extent of liver damage caused by the infection and aids in determining the need for antiviral treatment.
• Alcoholic Liver Disease: Elastography can help assess the impact of alcohol-related liver damage, such as fibrosis and cirrhosis, in people who have a history of excessive alcohol consumption.
• Autoimmune Hepatitis: Elastography is used to monitor liver stiffness in people who have autoimmune hepatitis, an immune system disorder that causes inflammation and damage to liver cells.
• Biliary Conditions: Biliary conditions such as primary biliary cirrhosis or primary sclerosing cholangitis can cause liver fibrosis. In these cases, elastography can help track the progression of fibrosis.